Type 2 diabetes patients who are treated with dipeptidyl peptidase-4 inhibitors have a significantly reduced risk for cardiovascular events, particularly myocardial infarction, compared with their peers who take placebo or other drugs, results of a meta-analysis show.
URL: http://www.news-medical.net/news/20121005/DPP-inhibitors-reduce-cardiovascular-events-in-diabetes-patients.aspx
No comments:
Post a Comment